Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 69:
70. The compound of claim 61, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein R2 is pyrazolyl, pyridinyl, pyrimidinyl, indazolyl, pyrrolopyridinyl, quinolinyl, or 4,5,6,7-tetrahydro-indazolyl, wherein the pyrazolyl, pyridinyl, pyrimidinyl, indazolyl, pyrrolopyridinyl, quinolinyl, or 4,5,6,7-tetrahydro-indazolyl is optionally substituted by 1, 2, 3, 4, or 5 independently selected R2e substituents.